It wasn't as frequently a death knell for the nutraceutical confectionery business as it was a wake-up call.

It wasn't as frequently a death knell for the nutraceutical confectionery business as it was a wake-up call. In February Pfizer Inc.'s Adams division halted U sales of its groundbreaking corpse Smarts line of fortified snack bars and fruit chews. The company wheeled out the bars and chews les than a year earlier, after spending significant R&D dollars creating a nutritious candy that tasted beneficial and backed the effort with a $70-million ad campaign.

Many in the confectionery business hailed the roll-out as a sign of the future: The first in a series